ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "cartilage"

  • Abstract Number: 44 • 2013 ACR/ARHP Annual Meeting

    Suppressor Of Cytokine Signaling 3 Negatively Modulates Leptin-Mediated Catabolic and Proinflammatory Effects In Cartilage – New Potential Mechanism To Target Obesity-Induced Osteoarthritis

    Anna Koskinen1, Katriina Vuolteenaho1, Riku Korhonen1, Teemu Moilanen1,2 and Eeva Moilanen1, 1The Immunopharmacology Research Group, University of Tampere School of Medicine and Tampere University Hospital, Tampere, Finland, 2Coxa Hospital for Joint Replacement, Tampere, Finland

    Background/Purpose: Adipocytokine leptin has been suggested to link obesity and osteoarthritis (OA). Initially leptin was found to regulate energy metabolism through central nervous system. More…
  • Abstract Number: 69 • 2013 ACR/ARHP Annual Meeting

    Interconnected Cellular Projections and Gap Junctions Mediate Metabolic Coupling Between Chondrocytes Located In Different Layers Of The Tissue: Cell-To-Cell Communication In Normal and Osteoarthritic Cartilage

    Maria Dolores Mayan1,2,3, Paula Carpintero-Fernández1,2, Raquel Gago-Fuentes1,2, Patricia Fernández-Puente1, Purificacion Filgueira-Fernandez1, Noa Goyanes1, Virgin Valiunas4, Peter Brink4, Gary Goldberg5 and Francisco J. Blanco6,7, 1Osteoarticular and Aging Research Group. Rheumatology Division, Biomedical Research Center (INIBIC). Hospital Universitario A Coruña, Xubias de Arriba 84, 15006, A Coruña, Spain, 2These authors contribute equally to this work, A Coruña, Spain, 3Correspondence to: [email protected] and [email protected], A Coruña, Spain, 4Department of Physiology and Biophysics. State University of New York, Stony Brook, New York, SC, 5Department of Molecular Biology. Medical Center Drive, University of Medicine and Dentistry of New Jersey, Stratford, NJ, 6Osteoarticular and Aging Res. Lab. CIBER-BBN. INIBIC- University of A Coruña, A Coruña, Spain, 7Proteo-Red/ISCIII, Madrid, Spain

    Background/Purpose: We have recently found that articular chondrocytes from human adults contain long cytoplasmic arms that cross the extracellular matrix and physically connect two chondrocytes…
  • Abstract Number: 238 • 2013 ACR/ARHP Annual Meeting

    Structural Predictors Of Ten Year Knee Cartilage Volume Loss

    Dawn Aitken1, Hussain Ijaz Khan1, Changhai Ding2, Leigh Blizzard3, Jean-Pierre Pelletier4, Johanne Martel-Pelletier4, Flavia Cicuttini5 and Graeme Jones2, 1Musculoskeletal Unit, Menzies Research Institute Tasmania, University of Tasmania, Hobart, 7000, Australia, 2Musculoskeletal Unit, Menzies Research Institute Tasmania, University of Tasmania, Hobart,7000, Australia, 3Statistics, Menzies Research Institute Tasmania, University of Tasmania, Hobart, Tasmania, Australia, 4Osteoarthritis Research Unit, University of Montreal Hospital Research Centre (CRCHUM), Montreal, QC, Canada, 5Department of Epidemiology and Preventive Medicine, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, 3004, Australia

    Background/Purpose: Cartilage volume loss is considered a key feature of knee osteoarthritis (OA) and increased loss over two years is associated with future knee replacement…
  • Abstract Number: 49 • 2013 ACR/ARHP Annual Meeting

    Chondrocyte-Specific Bone Morphogenetic Protein-2 Overexpression Results In Severe Aggravation Of Osteophyte Formation In Experimental Osteoarthritis Without Altering Cartilage Damage In Young Mice

    Esmeralda N. Blaney Davidson1, Elly L. Vitters2, Miranda B. Bennink3, Fons AJ Loo2, Wim B. van den Berg3 and Peter M. van der Kraan2, 1Rheumatology Research & Advanced Therapeutics, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, 2Rheumatology Research and Advanced Therapeutics, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, 3Rheumatology Research and Advanced Therapeutics, Department of Rheumatology, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands

    Background/Purpose: In murine osteoarthritis (OA) models chondrocytes surrounding lesions express elevated levels of Bone Morphogenetic Protein-2 (BMP2). This growth factor is well known for its…
  • Abstract Number: 2753 • 2013 ACR/ARHP Annual Meeting

    Relationship Of Pre-Radiographic MRI Lesions With Prevalent Frequent Knee Symptoms and Incident Persistent Knee Symptoms In Persons At Higher Risk For Knee Osteoarthritis

    Leena Sharma1, Joan S. Chmiel1, Orit Almagor1, Dorothy D. Dunlop2, Marc C. Hochberg3, Charles Eaton4, C. Kent Kwoh5, Rebecca D. Jackson6, Joan M. Bathon7, Ali Guermazi8, Frank Roemer9, Michel Crema8, W. Jerry Mysiw6 and Michael C. Nevitt10, 1Northwestern University, Chicago, IL, 2Northwestern University Feinberg School of Medicine, Chicago, IL, 3Medicine, University of Maryland School of Medicine, Baltimore, MD, 4Center for Primary Care and Prevention, Memorial Hospital of Rhode Island, Providence, RI, 5School of Medicine, Department of Medicine, Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, 6Ohio State University, Columbus, OH, 7Columbia University, New York, NY, 8Boston University, Boston, MA, 9Klinikum Augsburg, Augsburg, Germany, 10Epidemiology & Biostatistics, UCSF (University of California, San Francisco), San Francisco, CA

    Background/Purpose: The clinical significance of pre-radiographic MRI lesions in persons at risk for knee OA is unclear.  Understanding whether such lesions are inconsequential or early…
  • Abstract Number: 239 • 2013 ACR/ARHP Annual Meeting

    A Family History Of Knee Joint Replacement Increases The Progression Of Knee Joint Radiographic Osteoarthritis and Cartilage Volume Loss Over Ten Years

    Hussain Ijaz Khan1, Dawn Aitken1, Louisa Chou1, Andrew McBride1, Changhai Ding2, Jean Pierre Pelletier3,4, Johanne M. Pelletier5, Leigh Blizzard6, Flavia Cicuttini7 and Graeme Jones2, 1Musculoskeletal Unit, Menzies Research Institute Tasmania, University of Tasmania, Hobart, 7000, Australia, 2Musculoskeletal Unit, Menzies Research Institute Tasmania, University of Tasmania, Hobart,7000, Australia, 3Osteoarthritis Research Unit, University of Montreal Hospital Research Centre (CRCHUM), Notre-Dame Hospital, Montreal, QC, Canada, 4Rheumatology, Institut de rhumatologie de Montréal (IRM), Montréal, QC, Canada, 5Pharmacology, Osteoarthritis Research Unit, University of Montreal Hospital Research Centre (CRCHUM), Notre-Dame Hospital, Montreal, QC, Canada, 6Statistics, Menzies Research Institute Tasmania, University of Tasmania, Hobart, Tasmania, Australia, 7Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia

    Background/Purpose: Osteoarthritis (OA) is a disease of multifactorial origin with a modest but significant heritable effect for disease severity in the knee joint. The aim…
  • Abstract Number: 50 • 2013 ACR/ARHP Annual Meeting

    Cartilage Matrix Remodeling and Activation Of Canonical Wnt- Signaling Precedes Calcification and OA-Like Changes In Mice

    Jessica Bertrand1, Tabea Kräft2, Yvonne Nitschke3, Thelonius Hawellek4, Jan Hubert4, Lars Godmann5 and Thomas Pap5, 1Institute of Experimental Musculoskeletal Medicine (IEMM), University Hospital Münster, Münster, Germany, 2Inst, University Hospital Münster, Muenster, Germany, 3University Hospital Münster, Muenster, Germany, 4University Hospital Hamburg, Hamburg, Germany, 5Institute of Experimental Muskuloskeletal Medicine, University Hospital Münster, Münster, Germany

    Background/Purpose: Calcification of cartilage is a common finding during osteoarthritis (OA) and is directly linked to the severity of cartilage degradation. We have found in…
  • Abstract Number: 2729 • 2013 ACR/ARHP Annual Meeting

    Identification Of Osteoarthritis Patients With Chronic Inflammation Driven Disease Progression

    Anne Sofie Siebuhr1, Kristian Kjaer Petersen2, Lars Arendt-Nielsen3, Line Egsgaard2, Thomas Navndrup Eskehave4, Ole Simonsen5, Claus Christiansen4,6, Hans Christian Hoeck4, Morten Asser Karsdal7 and Anne C. Bay-Jensen8, 1Cartilage Biomarkers and Research, Nordic Bioscience, Herlev, Denmark, 2Department of Health Science and Technology, Faculty of Medicine, Aalborg University, Denmark, Center for Sensory-Motor Interaction, Aalborg, Denmark, 3Department of Health Science and Technology, Faculty of Medicine, Aalborg University, Center for Sensory-Motor Interaction, Aalborg, Denmark, 4Center for Clinical and Basic Research and C4Pain, Aalborg, Denmark, 5Frederikshavn Hospital, Frederikshavn, Denmark, 6Nordic Bioscience, Herlev, Denmark, 7Nordic Bioscience, Biomarkers and Research, Herlev, Denmark, 8Rheumatology, Nordic Bioscience, Biomarkers and Research, Herlev, Denmark

    Background/Purpose: In osteoarthritis (OA) it is evident that a subset of patients experiences chronic tissue inflammation and may benefit from anti-inflammatory treatment. The systemic inflammation…
  • Abstract Number: 80 • 2013 ACR/ARHP Annual Meeting

    Tidemark Duplication In Osteoarthritis: Evidence Of Incremental Progression?

    Martine P. Roudier1, Paul A. Manner2 and Peter A. Simkin3, 1Pathology, University of Washington, Seattle, WA, 2Orthopaedics, University of Washington, Seattle, WA, 3Div of Rheumatology, University of Washington, Seattle, WA

    ·         Background/Purpose: Osteoarthritis (OA) is commonly envisioned as a gradual, relentlessly progressive process of "wear and tear" leading to eventual joint failure.  As we see…
  • Abstract Number: 51 • 2013 ACR/ARHP Annual Meeting

    Collagen-Based Microspheres Delivering TGF-β3 For Mesenchymal STEM CELL Differentiation: An Innovative Strategy For Cartilage Engineering

    Marc Mathieu1, E Belamie2, M-N Labour2, Sylvain Vigier2, Christian Jorgensen3 and Daniele Noel4, 1INSERM U844, Montpellier, France, 2ICGM UMR 5253, MONTPELLIER, France, 3Department of therapy & Immuno-Rhumatology, Inserm U844, CHU saint-Eloi, Université Montpellier 1, CHU Lapeyronie, Montpellier, France, 4Inserm U844, UM1, Montpellier, France

    Background/Purpose: Because of a poor self-healing ability, joint cartilage undergoes progressive degradation in the course of aging or following traumatic injuries. One promising therapeutic approach…
  • Abstract Number: 2669 • 2013 ACR/ARHP Annual Meeting

    Treatment Of Knee Osteoarthritis Patients With Strontium Ranelate Reduces The Loss Of Cartilage Volume and Bone Marrow Lesions As Assessed By Magnetic Resonance Imaging: Data From The Phase III Strontium Ranelate Efficacy In Knee Osteoarthrtis Trial

    Johanne Martel-Pelletier1, Camille Roubille1, Jean-Pierre Raynauld1, François Abram2, Marc Dorais3, Philippe Delorme1 and Jean-Pierre Pelletier1, 1Osteoarthritis Research Unit, University of Montreal Hospital Research Centre (CRCHUM), Montreal, QC, Canada, 2Medical Imaging Research & Development, ArthroLab Inc., Montreal, QC, Canada, 3StatSciences Inc., Notre-Dame de l’Île Perrot, QC, Canada

    Background/Purpose: This study aimed to evaluate in a subpopulation of osteoarthritis (OA) patients from the SEKOIA Phase III trial the disease-modifying (DMOAD) effect of strontium…
  • Abstract Number: 84 • 2013 ACR/ARHP Annual Meeting

    New Formulation With Potential To Prevent and Treat Osteoporosis and Osteoarthritis

    A. Torrent1, E. Montell2, J. Vergés1, P. Dalmau3, R. Ruhí3, M.C. Carceller4, A. Blanco4, M.C. Terencio4, M.L. Ferrándiz4 and M.J. Alcaraz5, 1Pre-Clinical R&D Area, Pharmascience Division, BIOIBERICA S.A., Barcelona, Spain, 2Pharmascience Division, BIOIBERICA S.A., Barcelona, Spain, 3Technological Extraction Dept, BIOIBERICA S.A., Palafolls, Spain, 4Department of Pharmacology and IDM, University of Valencia, Burjassot, Spain, 5University of Valencia, Burjasot, Valencia, Spain

    Background/Purpose: Osteoarthritis (OA) is a multidimensional disease that affects all anatomical joint structures, particularly cartilage, synovium and subchondral bone. In turn, osteoporosis (OP) is a…
  • Abstract Number: 2670 • 2013 ACR/ARHP Annual Meeting

    Does Change In Femorotibial Cartilage Thickness Differ Between Acutely Anterior-Cruciate Ligament Injured Knees Treated With and Without Reconstructive Surgery

    Wolfgang Wirth1, Felix Eckstein1, Martin Hudelmaier2, Stefan Lohmander3 and Richard Frobell4, 1Anatomy & Musculoskeletal Research, Paracelsus Medical University, Salzburg, Austria, 2Paracelsus Medical University, Salzburg, Austria, 3Department of Orthopedics, Clinical Sciences Lund, Lund University, Lund, Sweden, 4Orthopedics, Clinical Sciences Lund, Lund University, Lund, Sweden

    Background/Purpose: An ACL tear is a serious knee injury, involving chronic alterations in joint biomechanics. The risk of developing knee OA after an ACL tear…
  • Abstract Number: 85 • 2013 ACR/ARHP Annual Meeting

    Cartilaginous Uric Acid Deposition In Advanced Osteoarthritis: Innocent Bystander Or Promotor Of Cartilage Destruction?

    Tim Bongartz1, Andre M Oliveira2, Rafael J Sierra3, Arlen D Hanssen3 and Michael J Taunton3, 1Rheumatology, Mayo Clinic, Rochester, MN, 2Pathology, Mayo Clinic, Rochester, MN, 3Orthopedic Surgery, Mayo Clinic, Rochester, MN

    Background/Purpose: Recent studies have suggested that synovial fluid uric acid could contribute to tissue inflammation, disease severity and progression of osteoarthritis (OA).  Intraarticular uric acid…
  • Abstract Number: 1950 • 2013 ACR/ARHP Annual Meeting

    Relationship Between Radiographic Joint Space Narrowing, Sonographic Cartilage Thickness and Anatomy In Rheumatoid Arthritis and Control Joints

    Peter Mandl1, Gabriela Supp2, Gabor Baksa3, Daniel Aletaha4, Reka Kurucz5, Dora Niedermayer6, Helga Radner7, Paul Studenic8, Peter V. Balint9 and Josef S. Smolen10, 1Medical University of Vienna, Vienna, Austria, 2Department of Internal Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria, 3Semmelweis University, Budapest, Hungary, 4Department of Internal Medicine III, Division of Rheumatology, Medical University Vienna, Vienna, Austria, 5National Institute of Rheumatology and Physiotherapy, Budapest, Hungary, 6PsAID taskforce, EULAR, Zurich, Switzerland, 7Department of Internal Medicine III; Division of Rheumatology, Medical University Vienna, Vienna, Austria, 8Department of Internal Medicine 3, Division of Rheumatology, Medical University of Vienna, Vienna, Austria, 9Rheumatology, National Institute of Rheumatology and Physiotherapy, Budapest, Hungary, 10Medical University of Vienna and Hietzing Hospital, Vienna, Austria

    Background/Purpose: To validate ultrasound (US) for measuring cartilage thickness, by evaluating cartilage thickness on cadaver specimens of metacarpophalangeal (MCP) joints by US and conventional measurement.…
  • « Previous Page
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology